Hospital partnership improves follow up scans, decreases long term risk after aortic repair
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-May-2026 18:15 ET (31-May-2026 22:15 GMT/UTC)
Study found that nearly half of Medicare Part D beneficiaries with cancer are projected to reach the annual out of pocket cap, with about one-third doing so as early as January. Enrollment in Medicare Prescription Plan would allow beneficiaries to spread these costs across the year — substantially reducing monthly payment volatility.
Researchers have developed a wearable, comfortable and washable device called Revoice that could help people regain the ability to communicate naturally and fluently following a stroke, without the need for invasive brain implants.
Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy. The study is published in Nature Communications.
University of Copenhagen and the Danish Technical University (DTU) enters into a broad partnership representing academia, the health-sector, government, industry, investors and innovation ecosystem actors to boost the development of the Innovation District Copenhagen.
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation sequencing is being explored as a complementary screening tool. A review published in Pediatric Investigation examines how next-generation sequencing could expand NBS from single-disease assays to genome-enabled, multi-disease screening approaches.
A new review reveals that Polygonum multiflorum (a traditional Chinese herbal medicine) can effectively combat androgenetic alopecia through multiple mechanisms: inhibiting the production of dihydrotestosterone, activating hair follicle regeneration pathways (Wnt/β-catenin, Shh), and improving scalp blood flow. Unlike existing drugs such as finasteride or minoxidil, it adopts a comprehensive multi-target approach, with fewer side effects and higher patient acceptance, supporting its development as a natural alternative for hair loss treatment.